Audrey Sirvent

机构：Centre National de la Recherche Scientifique, Université de Montpellier, La Ligue Contre le Cancer, Centre de Recherche en Biologie cellulaire de Montpellier · ORCID：0000-0003-4555-6312

发表论文 76 篇 · 总被引 2232 次 · h-index 23

代表论文

• Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer (2018 · EMBO Molecular Medicine · 被引 116)
• Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis (2016 · Clinical Cancer Research · 被引 113)
• Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer (2020 · Frontiers in Oncology · 被引 68)
• SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2 (2014 · Nature Communications · 被引 55)
• Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis (2020 · Cancers · 被引 33)
• CBL controls a tyrosine kinase network involving AXL , SYK and LYN in nilotinib‐resistant chronic myeloid leukaemia (2015 · The Journal of Pathology · 被引 29)